Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Treatment of essential hypertension with coenzyme Q10.

Langsjoen P, Langsjoen P, Willis R, Folkers K.

Mol Aspects Med. 1994;15 Suppl:S265-72.

PMID:
7752851
2.

Usefulness of coenzyme Q10 in clinical cardiology: a long-term study.

Langsjoen H, Langsjoen P, Langsjoen P, Willis R, Folkers K.

Mol Aspects Med. 1994;15 Suppl:s165-75.

PMID:
7752828
3.

Isolated diastolic dysfunction of the myocardium and its response to CoQ10 treatment.

Langsjoen PH, Langsjoen PH, Folkers K.

Clin Investig. 1993;71(8 Suppl):S140-4.

PMID:
8241699
4.

Coenzyme Q10 in essential hypertension.

Digiesi V, Cantini F, Oradei A, Bisi G, Guarino GC, Brocchi A, Bellandi F, Mancini M, Littarru GP.

Mol Aspects Med. 1994;15 Suppl:s257-63.

PMID:
7752838
6.
7.

Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure.

Rosenfeldt F, Hilton D, Pepe S, Krum H.

Biofactors. 2003;18(1-4):91-100. Review.

PMID:
14695924
8.

Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.

Wachtell K, Bella JN, Rokkedal J, Palmieri V, Papademetriou V, Dahlöf B, Aalto T, Gerdts E, Devereux RB.

Circulation. 2002 Mar 5;105(9):1071-6.

9.

Effect of long-term antihypertensive therapy on cardiac anatomy in patients with essential hypertension.

Drayer JI, Weber MA, Gardin JM, Lipson JL.

Am J Med. 1983 Sep 26;75(3A):116-20.

PMID:
6226188
10.

Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates.

Cicero AF, Derosa G, Miconi A, Laghi L, Nascetti S, Gaddi A.

Biomed Pharmacother. 2005 Jul;59(6):312-7.

PMID:
15932792
11.

Electrocardiographic and hemodynamic effects of coenzyme Q10 in healthy individuals: a double-blind, randomized controlled trial.

Shah SA, Sander S, Cios D, Lipeika J, Kluger J, White CM.

Ann Pharmacother. 2007 Mar;41(3):420-5. Epub 2007 Mar 6.

PMID:
17341532
12.

[Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].

Amado P, Vasconcelos N, Santos I, Almeida L, Nazaré J, Carmona J.

Rev Port Cardiol. 1999 Oct;18(10):897-906. Portuguese.

PMID:
10590654
13.

Effects of antihypertensive therapy on blood pressure and left ventricular hypertrophy in patients with severe hypertension.

Sumino H, Nakamura T, Kanda T, Sakamaki T, Sato K, Saito Y, Hoshino J, Kurashina T, Ono Z, Takahashi T, Ichikawa S, Kurabayashi M, Nagai R.

Jpn Heart J. 2000 May;41(3):339-48.

14.

Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. CoQ10 Drug Surveillance Investigators.

Baggio E, Gandini R, Plancher AC, Passeri M, Carmosino G.

Mol Aspects Med. 1994;15 Suppl:s287-94.

PMID:
7752841
15.

Reduction of cardiovascular structural changes by nifedipine GITS in essential hypertensive patients.

Agabiti-Rosei E, Zulli R, Muiesan ML, Salvetti M, Rizzoni D, Corbellini C, Monteduro C.

Blood Press. 1998 May;7(3):160-9.

PMID:
9758086
16.

Bioenergetics in clinical medicine. VIII. Adminstration of coenzyme Q10 to patients with essential hypertension.

Yamagami T, Shibata N, Folkers K.

Res Commun Chem Pathol Pharmacol. 1976 Aug;14(4):721-7.

PMID:
785564
18.
19.

Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.

Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.

Clin Ther. 2004 Sep;26(9):1436-45.

PMID:
15531006
20.

Effects of amlodipine and lisinopril on left ventricular mass and diastolic function in previously untreated patients with mild to moderate diastolic hypertension.

Beltman FW, Heesen WF, Smit AJ, May JF, de Graeff PA, Havinga TK, Schuurman FH, van der Veur E, Lie KI, Meyboom-de Jong B.

Blood Press. 1998 May;7(2):109-17.

PMID:
9657538

Supplemental Content

Support Center